Oral Lichenoid Reaction: An Uncommon Side Effect of Rituximab
Open Access
- 1 January 2019
- journal article
- case report
- Published by Wiley in Case Reports in Dentistry
- Vol. 2019 (1) , 3154856
Abstract
Oral lichenoid reactions (OLR) can be caused by systemic drug exposure. To the best of our knowledge, this is the second report describing a case of OLR induced by rituximab administration in a patient with a diagnosis of non‐Hodgkin B‐cell lymphoma. After 5 doses of rituximab, a typical pattern of OLP was identified with bilateral and symmetrical lesions on the buccal mucosa and on the right lingual margin. This temporal relationship suggested a probable association between oral lesions and drug therapy. The clinical diagnosis of a rituximab‐induced OLR was confirmed by an incisional biopsy reporting a histopathological result of lichenoid mucositis consistent with oral lichen planus. Because of the increasing use of rituximab, it is necessary to know and recognize this uncommon side effect.Keywords
This publication has 22 references indexed in Scilit:
- GA101 (a Novel Anti-CD20 Monoclonal Antibody)-Induced Lichenoid EruptionDermatology and Therapy, 2012
- Mucosal (oral and vulval) lichen planus in women: are angiotensin-converting enzyme inhibitors protective, and beta-blockers and non-steroidal anti-inflammatory drugs associated with the condition?Clinical and Experimental Dermatology, 2010
- Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatmentArthritis & Rheumatism, 2009
- Oral Lichenoid Drug Eruption: A Report of a Pediatric Case and Review of the LiteraturePediatric Dermatology, 2009
- Primary mantle-cell non-Hodgkin’s lymphoma of the tongueInternational Journal of Hematology, 2008
- Oral mucosal disease: Lichen planusBritish Journal of Oral and Maxillofacial Surgery, 2008
- Dactinomycin-Induced, Severe Lichenoid Eruption in a ChildPediatric Dermatology, 2006
- Naproxen‐induced lichen planus: report of 55 casesInternational Journal of Dermatology, 2006
- Tolerability and safety of rituximab (MabThera®)Cancer Treatment Reviews, 2005
- Oral lichen planus: Causes, diagnosis and managementAustralian Dental Journal, 2002